The University of Southampton
University of Southampton Institutional Repository

Health care costs of women with symptomatic vertebral fractures

Health care costs of women with symptomatic vertebral fractures
Health care costs of women with symptomatic vertebral fractures
Background: An important aspect of the economics of fracture prevention is averted fracture costs. However, while vertebral fractures represent a significant burden to society, quantifying their cost is difficult for several reasons. In this paper, we examine the health care costs of symptomatic vertebral fractures occurring in women aged 50 years and above in the UK.
Methods: We used a variety of data sources. The prevalence of pharmaceutical treatment for fracture prevention and number of general practitioner consultations, referrals, and hospital admissions associated with a diagnosis of vertebral fracture were identified from a case control study. For the unit cost of a general practitioner consultation, referral, and cost per inpatient day, we used 2002 data produced by the Personal Social Services Research Unit. Hospital Episode Statistics (HES) for 2001–2002 were used to estimate the median length of stay in hospital for women aged 50 years and above, and the Monthly Index of Medical Specialities (MIMS) was used to identify the costs of pharmaceutical treatments. Costs were discounted at 6%.
Results: From these data, we estimated that for the year prior and post diagnosis the average additional health care costs for those diagnosed with vertebral fracture were £165, £134, and £2314 for general practitioner consultations, referrals, and hospital admissions, respectively (i.e., £2613). The cost of pharmaceutical treatments prescribed for fracture prevention in the year following diagnosis was £97.
Discussion: Vertebral fractures are associated with significantly increased health care costs. These costs need to be set against the costs of fracture prevention.
health care costs, symptomatic vertebral fractures, women
8756-3282
383-386
Puffer, Suezann
47673647-f17d-44ad-9243-004c96e20b53
Torgerson, David J.
2b48b54a-4cc1-4833-864f-5b3d1b9fbc66
Sykes, David
24d2a384-f502-4564-8721-b649cb287cae
Brown, Pam
3a9b5233-c540-41a6-890d-da253ccf06d9
Cooper, Cyrus
e05f5612-b493-4273-9b71-9e0ce32bdad6
Puffer, Suezann
47673647-f17d-44ad-9243-004c96e20b53
Torgerson, David J.
2b48b54a-4cc1-4833-864f-5b3d1b9fbc66
Sykes, David
24d2a384-f502-4564-8721-b649cb287cae
Brown, Pam
3a9b5233-c540-41a6-890d-da253ccf06d9
Cooper, Cyrus
e05f5612-b493-4273-9b71-9e0ce32bdad6

Puffer, Suezann, Torgerson, David J., Sykes, David, Brown, Pam and Cooper, Cyrus (2004) Health care costs of women with symptomatic vertebral fractures. Bone, 35 (2), 383-386. (doi:10.1016/j.bone.2004.03.035).

Record type: Article

Abstract

Background: An important aspect of the economics of fracture prevention is averted fracture costs. However, while vertebral fractures represent a significant burden to society, quantifying their cost is difficult for several reasons. In this paper, we examine the health care costs of symptomatic vertebral fractures occurring in women aged 50 years and above in the UK.
Methods: We used a variety of data sources. The prevalence of pharmaceutical treatment for fracture prevention and number of general practitioner consultations, referrals, and hospital admissions associated with a diagnosis of vertebral fracture were identified from a case control study. For the unit cost of a general practitioner consultation, referral, and cost per inpatient day, we used 2002 data produced by the Personal Social Services Research Unit. Hospital Episode Statistics (HES) for 2001–2002 were used to estimate the median length of stay in hospital for women aged 50 years and above, and the Monthly Index of Medical Specialities (MIMS) was used to identify the costs of pharmaceutical treatments. Costs were discounted at 6%.
Results: From these data, we estimated that for the year prior and post diagnosis the average additional health care costs for those diagnosed with vertebral fracture were £165, £134, and £2314 for general practitioner consultations, referrals, and hospital admissions, respectively (i.e., £2613). The cost of pharmaceutical treatments prescribed for fracture prevention in the year following diagnosis was £97.
Discussion: Vertebral fractures are associated with significantly increased health care costs. These costs need to be set against the costs of fracture prevention.

This record has no associated files available for download.

More information

Published date: 2004
Keywords: health care costs, symptomatic vertebral fractures, women

Identifiers

Local EPrints ID: 25922
URI: http://eprints.soton.ac.uk/id/eprint/25922
ISSN: 8756-3282
PURE UUID: 27b9a780-2d0e-4d3f-b995-0635d6bcd9a8
ORCID for Cyrus Cooper: ORCID iD orcid.org/0000-0003-3510-0709

Catalogue record

Date deposited: 12 Apr 2006
Last modified: 18 Mar 2024 02:44

Export record

Altmetrics

Contributors

Author: Suezann Puffer
Author: David J. Torgerson
Author: David Sykes
Author: Pam Brown
Author: Cyrus Cooper ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×